Salarius Pharmaceuticals, Inc. Gains 33.4%

Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ) soared at $0.5, representing a gain of 33.4%. On Wed, Mar 09, 2022, SLRX:NASDAQ hit a New 2-Week Intraday Low of $0.34. The stock got featured on our News Catalysts scanner on Thu, Mar 10, 2022 at 04:27 PM in the 'EARNINGS' category. From Thu, Feb 24, 2022, the stock recorded 44.44% Up Days and 10.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ)

Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. It operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.